0001493152-24-035982.txt : 20240912 0001493152-24-035982.hdr.sgml : 20240912 20240912105015 ACCESSION NUMBER: 0001493152-24-035982 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240912 DATE AS OF CHANGE: 20240912 EFFECTIVENESS DATE: 20240912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensysce Biosciences, Inc. CENTRAL INDEX KEY: 0001716947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822755287 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523826 FILM NUMBER: 241294172 BUSINESS ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 263-4196 MAIL ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Leisure Acquisition Corp. DATE OF NAME CHANGE: 20170913 D 1 primary_doc.xml X0708 D LIVE 0001716947 Ensysce Biosciences, Inc. 7946 IVANHOE AVE, SUITE 201 LA JOLLA CA CALIFORNIA 92037 (858) 263-4196 DELAWARE None Leisure Acquisition Corp. Corporation true D Lynn Kirkpatrick 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Director Bob Gower 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director William Chang 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Andrew Benton 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Steve Martin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Adam Levin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Curtis Rosebraugh 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director David Humphrey 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Lee Rauch 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Other Health Care Decline to Disclose 06b false 2024-08-29 false true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 5055648 5055648 0 Includes totals from 3 public and non-public offerings simultaneously closed; specific consideration was not delineated for the non-public offerings, which involved warrants for up to 29,469,869 shares of common stock. false 4 454845 0 Includes commissions & fees received in a concurrent registered offering of $353,895, $35,000 (non-accountable expense), $50,000 (legal), $15,950 (clearing fees) and warrants to purchase 752,969 shares of common stock. 0 false Ensysce Biosciences, Inc. /s/ Lynn Kirkpatrick Dr. Lynn Kirkpatrick President and CEO 2024-09-12